| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |